DeepLeish: a deep learning based support system for the detection of Leishmaniasis parasite from Giemsa-stained microscope images
- PMID: 38890604
- PMCID: PMC11186139
- DOI: 10.1186/s12880-024-01333-1
DeepLeish: a deep learning based support system for the detection of Leishmaniasis parasite from Giemsa-stained microscope images
Abstract
Background: Leishmaniasis is a vector-born neglected parasitic disease belonging to the genus Leishmania. Out of the 30 Leishmania species, 21 species cause human infection that affect the skin and the internal organs. Around, 700,000 to 1,000,000 of the newly infected cases and 26,000 to 65,000 deaths are reported worldwide annually. The disease exhibits three clinical presentations, namely, the cutaneous, muco-cutaneous and visceral Leishmaniasis which affects the skin, mucosal membrane and the internal organs, respectively. The relapsing behavior of the disease limits its diagnosis and treatment efficiency. The common diagnostic approaches follow subjective, error-prone, repetitive processes. Despite, an ever pressing need for an accurate detection of Leishmaniasis, the research conducted so far is scarce. In this regard, the main aim of the current research is to develop an artificial intelligence based detection tool for the Leishmaniasis from the Geimsa-stained microscopic images using deep learning method.
Methods: Stained microscopic images were acquired locally and labeled by experts. The images were augmented using different methods to prevent overfitting and improve the generalizability of the system. Fine-tuned Faster RCNN, SSD, and YOLOV5 models were used for object detection. Mean average precision (MAP), precision, and Recall were calculated to evaluate and compare the performance of the models.
Results: The fine-tuned YOLOV5 outperformed the other models such as Faster RCNN and SSD, with the MAP scores, of 73%, 54% and 57%, respectively.
Conclusion: The currently developed YOLOV5 model can be tested in the clinics to assist the laboratorists in diagnosing Leishmaniasis from the microscopic images. Particularly, in low-resourced healthcare facilities, with fewer qualified medical professionals or hematologists, our AI support system can assist in reducing the diagnosing time, workload, and misdiagnosis. Furthermore, the dataset collected by us will be shared with other researchers who seek to improve upon the detection system of the parasite. The current model detects the parasites even in the presence of the monocyte cells, but sometimes, the accuracy decreases due to the differences in the sizes of the parasite cells alongside the blood cells. The incorporation of cascaded networks in future and the quantification of the parasite load, shall overcome the limitations of the currently developed system.
Keywords: Deep learning; Faster RCNN; Leishmaniasis; Microscopic image; Object detection; SSD; YOLOV5.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
A new diagnostic method and tool for cutaneous leishmaniasis based on artificial intelligence techniques.Comput Biol Med. 2025 Jun;192(Pt B):110313. doi: 10.1016/j.compbiomed.2025.110313. Epub 2025 May 12. Comput Biol Med. 2025. PMID: 40359677
-
A deep learning-based model for detecting Leishmania amastigotes in microscopic slides: a new approach to telemedicine.BMC Infect Dis. 2024 Jun 1;24(1):551. doi: 10.1186/s12879-024-09428-4. BMC Infect Dis. 2024. PMID: 38824500 Free PMC article.
-
Leveraging code-free deep learning for pill recognition in clinical settings: A multicenter, real-world study of performance across multiple platforms.Artif Intell Med. 2024 Apr;150:102844. doi: 10.1016/j.artmed.2024.102844. Epub 2024 Mar 13. Artif Intell Med. 2024. PMID: 38553153
-
Real-time PCR applications for diagnosis of leishmaniasis.Parasit Vectors. 2018 May 2;11(1):273. doi: 10.1186/s13071-018-2859-8. Parasit Vectors. 2018. PMID: 29716641 Free PMC article. Review.
-
Scoping Review of Deep Learning Techniques for Diagnosis, Drug Discovery, and Vaccine Development in Leishmaniasis.Transbound Emerg Dis. 2024 Jan 17;2024:6621199. doi: 10.1155/2024/6621199. eCollection 2024. Transbound Emerg Dis. 2024. PMID: 40303156 Free PMC article.
Cited by
-
Human-Validated Neural Networks for Precise Amastigote Categorization and Quantification to Accelerate Drug Discovery in Leishmaniasis.ACS Omega. 2024 Dec 24;10(1):1177-1187. doi: 10.1021/acsomega.4c08735. eCollection 2025 Jan 14. ACS Omega. 2024. PMID: 39829493 Free PMC article.
-
Enhanced Detection of Leishmania Parasites in Microscopic Images Using Machine Learning Models.Sensors (Basel). 2024 Dec 21;24(24):8180. doi: 10.3390/s24248180. Sensors (Basel). 2024. PMID: 39771915 Free PMC article.
-
Recombinant Leishmania-activated C kinase as a novel antigenic candidate for immuno-diagnosis of visceral leishmaniasis occurring in India and Brazil.Infect Dis Poverty. 2025 Jul 9;14(1):62. doi: 10.1186/s40249-025-01296-7. Infect Dis Poverty. 2025. PMID: 40635117 Free PMC article.
References
-
- von Chamier L, Laine RF, Henriques R. Artificial intelligence for microscopy: what you should know, Biochem. Soc. Trans 47;4:1029–1040, 2019, 10.1042/BST20180391. - PubMed
-
- Yu K-H, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2(10):719–31. 10.1038/s41551-018-0305-z. - PubMed
-
- Xing F, Yang L. Chapter 4 - Machine learning and its application in microscopic image analysis, in The Elsevier and MICCAI Society Book Series, G. Wu, D. Shen, and M. R. B. T.-M. L. and M. I. Sabuncu, Eds. Academic Press, 2016. 97–127.
-
- Mirbabaie M, Stieglitz S, Frick NRJ. Artificial intelligence in disease diagnostics: a critical review and classification on the current state of research guiding future direction. Health Technol (Berl) 2021;11(4):693–731. doi: 10.1007/s12553-021-00555-5. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources